Brad Canino
Stock Analyst at Guggenheim
(1.36)
# 3,559
Out of 4,996 analysts
14
Total ratings
54.55%
Success rate
-3.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brad Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Initiates: Buy | $110 | $50.60 | +117.39% | 1 | Sep 22, 2025 | |
| ORIC ORIC Pharmaceuticals | Assumes: Buy | $18 | $11.12 | +61.87% | 1 | Sep 4, 2025 | |
| RLAY Relay Therapeutics | Assumes: Buy | $15 | $5.17 | +190.14% | 1 | Sep 4, 2025 | |
| NUVL Nuvalent | Assumes: Buy | $122 | $81.39 | +49.90% | 1 | Sep 4, 2025 | |
| CCCC C4 Therapeutics | Initiates: Buy | $8 | $2.23 | +258.74% | 1 | Sep 4, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $72 | $23.23 | +209.94% | 1 | Sep 4, 2025 | |
| KURA Kura Oncology | Initiates: Neutral | n/a | $9.05 | - | 1 | Sep 4, 2025 | |
| BDTX Black Diamond Therapeutics | Initiates: Buy | $8 | $3.40 | +135.29% | 1 | Sep 4, 2025 | |
| SMMT Summit Therapeutics | Initiates: Buy | $40 | $20.95 | +90.93% | 1 | Sep 4, 2025 | |
| PYXS Pyxis Oncology | Initiates: Buy | $5 | $2.14 | +133.64% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $450 | $7.57 | +5,844.52% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $55 | $16.60 | +231.33% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $39.04 | -23.16% | 2 | Mar 31, 2021 |
Celcuity
Sep 22, 2025
Initiates: Buy
Price Target: $110
Current: $50.60
Upside: +117.39%
ORIC Pharmaceuticals
Sep 4, 2025
Assumes: Buy
Price Target: $18
Current: $11.12
Upside: +61.87%
Relay Therapeutics
Sep 4, 2025
Assumes: Buy
Price Target: $15
Current: $5.17
Upside: +190.14%
Nuvalent
Sep 4, 2025
Assumes: Buy
Price Target: $122
Current: $81.39
Upside: +49.90%
C4 Therapeutics
Sep 4, 2025
Initiates: Buy
Price Target: $8
Current: $2.23
Upside: +258.74%
Janux Therapeutics
Sep 4, 2025
Initiates: Buy
Price Target: $72
Current: $23.23
Upside: +209.94%
Kura Oncology
Sep 4, 2025
Initiates: Neutral
Price Target: n/a
Current: $9.05
Upside: -
Black Diamond Therapeutics
Sep 4, 2025
Initiates: Buy
Price Target: $8
Current: $3.40
Upside: +135.29%
Summit Therapeutics
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $20.95
Upside: +90.93%
Pyxis Oncology
Sep 4, 2025
Initiates: Buy
Price Target: $5
Current: $2.14
Upside: +133.64%
Mar 31, 2021
Initiates: Neutral
Price Target: $450
Current: $7.57
Upside: +5,844.52%
Mar 31, 2021
Initiates: Outperform
Price Target: $55
Current: $16.60
Upside: +231.33%
Mar 31, 2021
Initiates: Outperform
Price Target: $30
Current: $39.04
Upside: -23.16%